Back to Search
VARANT ARZOUMANIAN, MD
MD
Hematology & Oncology Physician
NPI: 1790904027IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
E5432(AR)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1996
Research & Publications (4)
Suppression of abnormal karyotype predicts superior survival in multiple myeloma.
PMID 18200039·Leukemia·2008
4-observational
Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease.
PMID 17156398·Br J Haematol·2007
2-rct
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.
PMID 17023574·Blood·2007
8-other
Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I.
PMID 11007058·Eur J Haematol·2000
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1001 TOWSON AVE
FORT SMITH, AR 72901 - Phone
- (479) 709-7435
Quick Facts
- NPI
- 1790904027
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 30
- Publications
- 4
Are you this provider?
Claim Your Profile